MAD2B-mediated cell cycle reentry of podocytes is involved in the pathogenesis of FSGS
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 17 (15) , 4396-4408
Abstract
Rationale: Focal segmental glomerulosclerosis (FSGS) is characterized by the dysfunction of “post-mitotic” podocytes. The reentry of podocytes in the cell cycle will ultimately result in cell death. Mitotic arrest deficient 2-like protein 2 (MAD2B), an inhibitor of anaphase-promoting complex (APC)/cyclosome, precisely controls the metaphase to anaphase transition and ordered cell cycle progression. However, the role of MAD2B in FSGS podocyte injury remains unknown.Keywords
This publication has 27 references indexed in Scilit:
- When ubiquitination meets phosphorylation: a systems biology perspective of EGFR/MAPK signallingCell Communication and Signaling, 2013
- The incidence of primary glomerulonephritis worldwide: a systematic review of the literatureNephrology Dialysis Transplantation, 2010
- Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox geneFree Radical Biology and Medicine, 2010
- Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cellsJournal of Clinical Investigation, 2009
- Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancerNature Reviews Molecular Cell Biology, 2008
- The spectrum of podocytopathies: A unifying view of glomerular diseasesKidney International, 2007
- Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancerInternational Journal of Cancer, 2006
- Mitotic cell cycle proteins increase in podocytes despite lack of proliferationKidney International, 2003
- MAD2B is an inhibitor of the anaphase-promoting complexGenes & Development, 2001
- Mitosis and the Presence of Binucleate Cells among Glomerular Podocytes in Diseased Human KidneysNephron, 1995